易明医药
(002826)
| 流通市值:26.66亿 | | | 总市值:27.61亿 |
| 流通股本:1.84亿 | | | 总股本:1.91亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 562,069,352.56 | 359,623,665.2 | 182,577,229.06 | 636,272,038.57 |
| 营业总成本 | 466,546,362.35 | 305,912,646.03 | 157,841,477.13 | 573,356,762.17 |
| 其他经营收益 | | | | |
| 营业利润 | 124,698,272.83 | 83,057,547.65 | 24,880,525.1 | 100,612,923.19 |
| 利润总额 | 123,416,185.21 | 83,017,139.09 | 24,908,506.84 | 113,670,507.43 |
| 净利润 | 99,358,968.43 | 66,679,694.56 | 19,648,370.41 | 93,124,133.45 |
| 每股收益 | | | | |
| 其他综合收益 | -1,121,308.17 | -938,922.36 | -653,642.24 | -1,071,743.36 |
| 综合收益总额 | 98,237,660.26 | 65,740,772.2 | 18,994,728.17 | 92,052,390.09 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 829,884,042.81 | 790,670,109.65 | 723,274,292.79 | 633,682,261.96 |
| 非流动资产: | | | | |
| 非流动资产合计 | 403,383,693.42 | 405,854,608.43 | 380,016,559.21 | 383,992,112.77 |
| 资产总计 | 1,233,267,736.23 | 1,196,524,718.08 | 1,103,290,852 | 1,017,674,374.73 |
| 流动负债: | | | | |
| 流动负债合计 | 383,579,298.68 | 328,227,199.94 | 260,459,447.88 | 196,680,793.61 |
| 非流动负债: | | | | |
| 非流动负债合计 | 4,493,444.58 | 4,652,310.03 | 4,811,175.48 | 4,970,040.93 |
| 负债合计 | 388,072,743.26 | 332,879,509.97 | 265,270,623.36 | 201,650,834.54 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 845,194,992.97 | 863,645,208.11 | 838,020,228.64 | 816,023,540.19 |
| 股东权益合计 | 845,194,992.97 | 863,645,208.11 | 838,020,228.64 | 816,023,540.19 |
| 负债和股东权益合计 | 1,233,267,736.23 | 1,196,524,718.08 | 1,103,290,852 | 1,017,674,374.73 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 659,475,616.77 | 444,530,423.73 | 214,869,585.51 | 781,780,088.72 |
| 经营活动现金流出小计 | 422,025,491.08 | 270,574,482.14 | 135,499,804.51 | 658,059,922.93 |
| 经营活动产生的现金流量净额 | 237,450,125.69 | 173,955,941.59 | 79,369,781 | 123,720,165.79 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,283,061,493.5 | 881,961,874.79 | 200,401,833.34 | 720,659,041.13 |
| 投资活动现金流出小计 | 1,613,953,708.37 | 1,111,459,740.24 | 400,818,138.91 | 722,495,636.16 |
| 投资活动产生的现金流量净额 | -330,892,214.87 | -229,497,865.45 | -200,416,305.57 | -1,836,595.03 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 90,210,933.95 | 57,444,000 | 28,644,000 | 46,618,171.39 |
| 筹资活动现金流出小计 | 110,088,885.29 | 39,772,203.9 | 11,286,653.67 | 57,501,048.82 |
| 筹资活动产生的现金流量净额 | -19,877,951.34 | 17,671,796.1 | 17,357,346.33 | -10,882,877.43 |
| 汇率变动对现金及现金等价物的影响 | -467,212.07 | -457,296.9 | -418,483.11 | -734,015.58 |
| 现金及现金等价物净增加额 | -113,787,252.59 | -38,327,424.66 | -104,107,661.35 | 110,266,677.75 |
| 期末现金及现金等价物余额 | 423,877,562.54 | 499,337,390.47 | 433,557,153.78 | 537,664,815.13 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -38,327,424.66 | - | 110,266,677.75 |